eBwell Blood Glucose Monitoring System - Taiwan Registration 8909b21a6b1d1da1ba27a52ac59fcd89
Access comprehensive regulatory information for eBwell Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8909b21a6b1d1da1ba27a52ac59fcd89 and manufactured by Hsinchu General Factory of Weishi Biotechnology Co., Ltd. The authorized representative in Taiwan is Hsinchu General Factory of Weishi Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
8909b21a6b1d1da1ba27a52ac59fcd89
Ministry of Health Medical Device Manufacturing No. 005622
Product Details
This product is designed for diabetics and healthcare professionals to measure blood glucose levels using whole blood collected at your fingertips. Performance Modification is as follows: This product is designed for diabetics and professionals, using whole blood collected at the fingertips to measure blood glucose concentration.
A Clinical chemistry and clinical toxicology
A1345 Glucose Test System
Produced in Taiwan, China
Dates and Status
Jun 30, 2017
Jun 30, 2027